Temporal changes in pediatric respiratory syncytial virus and adenovirus positivity across COVID-19-related periods: A six-year retrospective cohort study
Abstract
Objective: To describe temporal changes in respiratory syncytial virus (RSV) and adenovirus positivity among children tested across three COVID-19-related periods.
Methods: This single-center retrospective cohort study included 8,253 children aged 0–18 years who underwent concurrent RSV and adenovirus antigen testing for suspected acute respiratory infection from January 2018 through June 2023. Periods were defined as pre-pandemic (January 2018–February 2020), restrictive pandemic (March 2020–May 2021), and post-restriction (June 2021–June 2023). Positivity proportions were compared by period. Unadjusted odds ratios (ORs) were calculated from period-specific counts using the pre-pandemic period as reference.
Results: RSV was detected in 266 children (3.2%) and adenovirus in 612 (7.4%). RSV positivity was 1.5% (55/3,785) pre-pandemic, 1.2% (13/1,055) during restrictions, and 5.8% (198/3,413) post-restriction. Relative to the pre-pandemic period, the odds of RSV positivity did not differ during restrictions (OR 0.85, 95% CI 0.46–1.55) but were higher post-restriction (OR 4.18, 95% CI 3.09–5.65). Adenovirus positivity was 8.8%, 10.2%, and 5.0%, respectively; corresponding ORs were 1.18 (95% CI 0.94–1.48) and 0.54 (95% CI 0.45–0.66).
Conclusion: Among clinically selected children who were tested, RSV and adenovirus positivity followed different temporal patterns. These unadjusted associations should not be interpreted as causal effects of specific public-health measures because seasonality, testing practices, and healthcare-seeking behavior may have differed across periods.Keywords
References
Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Pineda RF, et al. Decreased influenza activity during the COVID-19 pandemic—United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(37):1305-9. https://doi.org/10.15585/mmwr.mm6937a6
Sullivan SG, Carlson S, Cheng AC, Chilver MB, Dwyer DE, Irwin M, et al. Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020. Euro Surveill. 2020;25(47):2001847. https://doi.org/10.2807/1560-7917.ES.2020.25.47.2001847
Huh K, Jung J, Hong J, Kim M, Ahn JG, Kim JH, et al. Impact of nonpharmaceutical interventions on the incidence of respiratory infections during the coronavirus disease 2019 (COVID-19) outbreak in Korea: a nationwide surveillance study. Clin Infect Dis. 2021;72(7):e184-91. https://doi.org/10.1093/cid/ciaa1682
Tempia S, Walaza S, Bhiman JN, McMorrow ML, Moyes J, Mkhencele T, et al. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveill. 2021;26(29):2001600. https://doi.org/10.2807/1560-7917.ES.2021.26.29.2001600
Foley DA, Yeoh DK, Minney-Smith CA, Martin AC, Mace AO, Sikazwe CT, et al. The interseasonal resurgence of respiratory syncytial virus in Australian children following the reduction of coronavirus disease 2019-related public health measures. Clin Infect Dis. 2021;73(9):e2829-30. https://doi.org/10.1093/cid/ciaa1906
Agha R, Avner JR. Delayed seasonal RSV surge observed during the COVID-19 pandemic. Pediatrics. 2021;148(3):e2021052089. https://doi.org/10.1542/peds.2021-052089
Bardsley M, Morbey RA, Hughes HE, Beck CR, Watson CH, Zhao H, et al. Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study. Lancet Infect Dis. 2023;23(1):56–66. https://doi.org/10.1016/S1473-3099(22)00525-4
Baker RE, Park SW, Yang W, Vecchi GA, Metcalf CJE, Grenfell BT. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci U S A. 2020;117(48):30547-53. https://doi.org/10.1073/pnas.2013182117
Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047-64. https://doi.org/10.1016/S0140-6736(22)00478-0
Hall CB, Weinberg GA, Blumkin AK, Edwards KM, Staat MA, Schultz AF, et al. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. 2013;132(2):e341-8. https://doi.org/10.1542/peds.2013-0303
Lynch JP 3rd, Fishbein M, Echavarria M. Adenovirus. Semin Respir Crit Care Med. 2011;32(4):494-511. https://doi.org/10.1055/s-0031-1283287
Echavarría M. Adenoviruses in immunocompromised hosts. Clin Microbiol Rev. 2008;21(4):704-15. https://doi.org/10.1128/CMR.00052-07
